Chemical Structure (Mil02 0002 01)
Milrinone Lactate Injection, Solution
Product Images NDC 71288-200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate (NDC 71288-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – 10 mg Per 10 mL Vial Label (Mil02 0002 02)
This is a drug called Milrinon Lactate Injection, used for intravenous use only. It comes in a 10mL single-dose vial with a strength of 10mg per 10mL, which means 1mg per mL. The drug is manufactured by Meitheal Pharmaceuticals for the US market. There are also alphanumeric codes that could be related to its production and quality control.*
Principal Display Panel – 10 mg Per 10 mL Carton (Mil02 0002 03)
This is a description of a medication called Milrinone Lactate Injection, which is designed for intravenous use only. Each 1 mL of the solution contains Mirinone Bctate equivalent to 1 mg Mirinone and 47 mg of Dextrose Anhydrous. The solution is to be used in its entirety after an initial use, and the unused portion discarded. The medication must be stored at a temperature range of 20°C to 25°C to avoid freezing. Each box contains 10 single-dose vials of 10 mL each.*
Principal Display Panel – 20 mg Per 20 mL Vial Label (Mil02 0002 04)
Principal Display Panel – 20 mg Per 20 mL Carton (Mil02 0002 05)
Milrinone Lactate Injection is a type of medication used for intravenous use only. The usual dosage should be followed according to the package insert. Each ml contains milrinone lactate that is equivalent to 1 mg of milrinone and 47 mg of Dextrose Anhydrous. The solution contains lactic acid or sodium hydroxide that has a pH adjusted between 3.2 and 4.0. The total concentration of lactic acid can vary between 0.95 mg per mL and 1.29 mg per mL. Milrinone Lactate Injection is a preservative-free solution that should not be frozen and should be stored at 20°C to 25°C. The container closure of this medication is not made with natural rubber latex. NDC 7128820021 is the number given to this medication. The available size is 1020 mL single-dose vials.*
Principal Display Panel – 50 mg Per 50 mL Vial Label (Mil02 0002 06)
Milrinone Lactate Injection, USP is an intravenous medication manufactured by Meitheal Pharmaceuticals in the USA. The medication has an NDC code of 71288-200-50 and is supplied in a single-dose 50 mL vial containing 50 mg of the medication per 50 mL (1 mg/mL). The medication is used for intravenous use only.*
Principal Display Panel – 50 mg Per 50 mL Carton (Mil02 0002 07)
This is a product description of Milrinone Injection, USP used for intravenous use only. It is available in a 50 mL single-dose vial with a concentration of 0.85 mg/ml Milrinone and 47 mg/ml lactate. The pH of the solution is adjusted between 3.2 and 4.0 using acetic acid or sodium hydroxide. This product should be stored at 20°C to 25°C and should be discarded after single use. The product has no preservatives and is free of natural rubber latex. This product is manufactured by Meitheal Pharmaceuticals, located in Chicago, IL.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
